2020 M2D2 $200K Challenge Pitch-Off & Awards Celebration

M2D2 is an incubator program for early stage medical device and biotech startups, a joint program between University of Massachusetts Lowell and University of Massachusetts Medical School. No affiliation with University of Massachusetts required and no strings attached.M2D2 is a lifeline for emerging medical device and biotech companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the two UMass campuses.M2D2 offers wet lab space (shared w/equipment and private) and office space, as well as access to medical, business, engineering and industry experts.

M2D2

In response to the coronavirus pandemic, we're taking our signature pitch event online. Join us — REGISTRATION IS FREE!

LIVE via Zoom from UMass M2D2

<h3>Calling all Investors, Medical Device Innovators, Biotech Entrepreneurs, Academics, Students, and Life Sciences Industry Professionals:</h3>Join the worldwide life sciences community online as the $200K Challenge finalists selected through a competitive process last spring pitch their innovations virtually to our panel of judges. At stake: a share of a $200,000 purse of sponsor-provided, in-kind resources that can help take an innovation to the next level -- or even to market!(Examples of in-kind resources include lab space, equipment, and legal/regulatory guidance)We've seen past winners advance to larger funding rounds, commence clinical studies, and enter strategic partnerships with global life sciences companies. The $200K Challenge is the place to see what's up-and-coming in life sciences innovation.<h3>TICKETS ARE FREE—CHOOSE ONE OR BOTH EVENTS:</h3>Finalist Pitch-Off — Thursday, September 17 @ 5pm ET Our 15 Finalists will each have four minutes to make their cases to our panel.Awards Celebration — Thursday, October 1st @ 5pm ET Join us for the announcement of the $200K Challenge winners!

Mary Ann Picard, M2D2 Director of Operations, commented on the Finalist selection process: “Every year, the Challenge gives us a peek at amazing early-stage ideas in medical devices, medtech, biotech, and therapeutics. It’s an all-consuming task to sort through dozens and dozens of entrants. But it’s also exciting and energizing because the entries are always novel and innovative."

<h1>Meet 2020&#x27;s $200K Challenge Finalists</h1>15 finalists have been selected from more than 250 applicants for the 9th Annual M2D2 $200K Challenge. This year’s participation sets a new record for the competition:<a href="https://aidar.com/alhome/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Aidar Health</a> – MouthLab is a non-invasive, at-home, rapid health assessment device for early detection and management of exacerbation in COPD patients.AiM Medical Robotics – Novel robotics platform with AI and machine learning.<a href="https://blogs.uml.edu/m2d2/2020/04/20/meet-200k-finalist-arrow-diagnostics/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Arrow Dx</a> – A sensitive, inexpensive, user-friendly test to screen early for NAFLD &amp; NASH.<a href="https://blogs.uml.edu/m2d2/2020/05/07/m2d2-200k-challenge-finalist-craniosense/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">CranioSense</a> – IPASS device that helps save lives by rapidly assessing a patient’s intracranial pressure non-invasively following traumatic brain injury.<a href="https://blogs.uml.edu/m2d2/2020/07/17/meet-200k-challenge-finalist-cx-therapeutics/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Cx Therapeutics</a> – A novel device to reduce preterm birth and improve outcomes for pregnant women with cervical insufficiency.<a href="https://blogs.uml.edu/m2d2/2020/08/14/meet-200k-challenge-finalist-exonanorna/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">ExonanoRNA</a> – Platform biotechnology company developing a new class of RNA nanotechnology-based therapeutics for cancer treatment.<a href="https://blogs.uml.edu/m2d2/2020/07/24/meet-a-200k-finalist-hyalex/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Hyalex Orthopaedics</a> – Transformational synthetic cartilage technology and implant systems for diseased and damaged joints.Lowell Therapeutics – Small molecule short-acting anticoagulant and will be the only approved anticoagulant for ICU patients in need of an artificial kidney.<a href="https://blogs.uml.edu/m2d2/2020/07/31/meet-a-200k-challenge-finalist-microbiomed-corporation/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">MicroBioMed</a> – Patented vaginal biomechanics analyzer is an operator-independent measurement device to quantitatively study vaginal wall skin properties.Navigation Sciences – An image-guided surgical navigation system for real-time GPS guidance to precisely locate and excise tumors with optimal margins.<a href="https://blogs.uml.edu/m2d2/2020/08/26/meet-a-200k-challenge-finalist-oriel-research-therapeutics/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Oriel Research Therapeutics</a> – A platform for early detection of diseases using AI-Learning and Deep Neural Network methods.<a href="https://blogs.uml.edu/m2d2/2020/07/10/m2d2-200k-challenge-finalist-profilagen/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Prolifagen</a> – Developing a medicine for regeneration of cardiac muscle in patients with large myocardial infarcts, with the objective to prevent development of heart failure.RBI Medical – Selective nerve stimulation platform offers patients better therapy options for life-altering conditions.Savran Technologies – A unique and patented “lab-on-a-chip” technology to capture rare (~1 in a billion) cells from a tube of ordinary blood.<a href="https://blogs.uml.edu/m2d2/2020/04/27/meet-200k-challenge-finalist-amachumu-bio/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Amachumu Bio</a> – A supplement to cure intestinal worms that disproportionately affect individuals in developing countries.

<h3>Keynote Speaker:</h3><h3>Jennifer Griffin, Ph.D. </h3>Vice President, Industry Strategy and Investments , Massachusetts Life Sciences Center

Jennifer has over 10 years of experience working to develop life science technologies in the public, private and academic sectors. She has advised investors, universities, and management teams around the globe and is currently responsible for developing the State’s investment strategy to strengthen the life sciences industry in Massachusetts. Jennifer joined the MLSC in September of 2017 as the Vice President, Industry Strategy and Investments. In her role, she develops and manages the investment strategy for a variety of initiatives and partnerships for the life sciences industry, including with private, public, and nonprofit stakeholders. These include investments targeted at seeding early-stage companies, supporting underrepresented entrepreneurs, accelerating industry –academia partnerships, as well as attracting and retaining life science companies in the Commonwealth of Massachusetts.

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

2020 M2D2 $200K Challenge Pitch-Off & Awards Celebration

More events from M2D2

Discover more events from M2D2, from Science & Tech to other experiences you might love.

2020 M2D2 $200K Challenge Pitch-Off & Awards Celebration

More events from M2D2

Discover more events from M2D2, from Science & Tech to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.